CRWD · CrowdStrike Holdings, Inc. — research history

CRWD triggered on an 8-Form-4 cluster over 14 days and a fresh June 22 8-K (annual meeting results + officer liability charter amendment). However, all insider transactions are Rule 10b5-1 pre-scheduled SELLING by CEO George Kurtz — not open-market purchases. No actual insider buying was detected in the filing set. The company announced AWS Summit New York AI/cloud security expansions on June 17 and a July 2 4:1 stock split, but no earnings catalyst exists until September 1 (Q2 FY2027). CRWD trades at ~108x forward P/E and ~2836x EV/EBITDA — deeply rich vs. cybersecurity peers Zscaler (~27x) and Palo Alto Networks (~35x). The June run from ~644 to 782 (+21%) was a sharp pre-split re-rating; the stock is now 14% below its 52-week high and RSI has normalized to neutral territory with a recent bearish MACD cross. No material mispricing exists, no insider buying signal, and earnings are >10 weeks away.

Extreme valuation premium (105x Fwd P/E, 2765x EV/EBITDA) combined with $10M+ in insider selling and active anti-signals (dilution, pump signals) leaves no margin of safety or structural edge for either long or income trades.

CrowdStrike delivered a strong FQ1 FY2027 beat on June 3 ($1.39B revenue +26% YoY, EPS $1.10 vs $1.067 est) with meaningfully raised full-year guidance and announced its first-ever 4:1 stock split effective July 2, yet the stock sold off ~15% from its intraday high of $785 to $658 by June 8 — a textbook 'beat but priced for perfection' reaction. The Form 4 cluster that triggered this investigation consists entirely of scheduled 10b5-1 selling by CEO George Kurtz and director Sameer Gandhi; there is zero open-market insider buying in the dataset, which is an anti-signal worth noting. With forward P/E at ~105x, EV/EBITDA near 2765x, FCF yield under 1.2%, and Goldman Sachs aggressively resetting its target post-earnings, the stock has pulled back from nosebleed territory but remains richly valued with limited near-term upside unless growth accelerates beyond already-elevated guidance.

Hard skip: no candidate contracts meet the OI ≥200 liquidity threshold (max OI is 188). Additionally, catalyst is only 1 DTE, falling outside the 7-45 DTE clarity window and triggering near-term constraints.

CrowdStrike reports Q1 FY2027 earnings after market close on June 3, 2026 (DTE: 1 day to print; options expire June 5 — the closest expiry lands ~2 calendar days post-print). The stock is at all-time highs of $769, up +88% YTD from sub-$370 April lows. RSI(14) = 82.6 indicates extreme overbought but momentum remains intact above the 20/50/200-day MAs. Historical earnings data shows consistent EPS beats: last four quarters averaged ~2-12% positive surprise (10.62%, 12.05%, 1.98%, 1.56%). The ATM June 5 straddle (770P at $39.63 mid + 770C at $39.20 mid = $78.83 total) implies a market-priced move of ~12.7% ($97 in either direction). Historical realized average absolute post-earnings move across the last four quarters is approximately 6.68%, creating an implied-vs-realized gap of roughly +80%. This strongly suggests options are pricing excessive vol, favoring defined-risk structures over naked long premium. Direction signals are unanimously bullish: analyst upgrades (Morgan Stanley May 20; Wedbush June 2 AI cybersecurity tailwind article), positive software sector momentum (+40% from April lows as noted in June 2 sector coverage), and call-skew dominance across the chain (770C IV = 123.7%). Insider Form 4 filings cluster around RSU vesting (Code A) rather than open-market purchases — no verifiable Code P buys in the last 90 days. Given magnitude edge (+80% implied above realized) AND a unanimous bullish direction lean, this is a catalyst_setup: market overpaying vol suggests avoiding naked long premium; directional conviction favors defined-risk debit spreads on the call side.

The Form 4 cluster trigger was investigated thoroughly. All 30 recent Form 4s reviewed are pre-scheduled SELLING under 10b5-1 plans adopted months ago — by CEO George Kurtz (January 2026 plan) and director Sameer Gandhi (June 2025 plan). There are ZERO open-market purchases from any insider in the past 90 days. The 'cluster' reflects multi-day systematic selling split across multiple Form 4 documents due to EDGAR row limits, not conviction buying. CRWD is at an all-time high of $782 with a forward P/E of ~127x and RSI at 86.7 — deeply overextended on every traditional metric. Next earnings are June 3, 2026 (after close), so IV will be elevated into the announcement. There is no fundamental mispricing; the stock is fully valued and technically extended.

anti_signals: RSI(14) at 83.8 — deeply overbought into event, Stock at all-time high with zero pullback buffer ahead of binary catalyst, George Kurtz (CEO) executed Rule 10b5-1 sales May 22–26 — not directional but signals profit-taking posture, Implied move (5.36%) only modestly exceeds realized (4.45%) — no strong vol premium edge

CRWD reports Q1 FY2027 earnings on June 3, 2026 after market close. The stock has surged ~90% in 90 days to an all-time high of $731 (RSI=83.8), driven by AI cybersecurity momentum and sector rotation following Snowflake's blowout results. Earnings history shows consistent positive EPS surprises (+1.6% to +12% beat rate across the last four quarters). The June 5 expiry offers 2 DTE post-event — razor-thin gamma but valid for a defined-risk debit structure. Implied ATM straddle move is ~$39 (~5.36%), marginally above the historical realized avg of $32 (4.45%) — no overwhelming magnitude edge, so direction signals must carry the trade. Options flow shows 88% call-dollar bias with a whale block at $800 strike (V/OI=10x), and CRWD was named a Gartner Leader in Endpoint Protection for the seventh consecutive time on May 29. Insider George Kurtz sold ~$26K in shares on May 22-26 per Rule 10b5-1 plan — not directional. Analyst revisions are mixed, but Wedbush reiterated a bullish view on ARR and AI tailwinds. The combination of call skew dominance + sector momentum + consistent earnings beats points to a defined-risk debit call spread over a straddle or put structure.

The investigation trigger flagged Form 4 cluster activity as a potential insider-buying signal. However, every single Form 4 filing in the past 14 days is an SALE (disposal code), all executed via pre-existing Rule 10b5-1 plans adopted January 6 and June 27, 2025 — not discretionary open-market purchases reflecting current conviction. George Kurtz alone sold ~$10M+ worth of shares across May 13–26 via his automated plan as the stock surged from ~$560 to $731. This is a volume-selling program, not insider accumulation. The stock sits at an all-time high with forward P/E of ~118x and RSI 83.8 — deeply overbought. While Q1 earnings on June 3 provide a catalyst window and the company announced a $500M buyback expansion, there is no mispricing (up 113% from February lows), no insider buying edge, and extreme valuation premium. This is not a promising long setup; at this price with this IV (~63%), it is at best an income/call-coverage candidate.

anti_signals: RSI(14) at 83.4 — extreme overbought entering catalyst; any 'buy the rumor' unwind on print will trigger sharp reversal, Stock up ~60% in prior 30 days — priced-for-perfection risk is very high heading into earnings, Sector headwinds visible: SentinelOne cut jobs and gave tepid guidance; Zscaler missed on sales turnover concerns, Rising operating cost environment acknowledged across cybersecurity peers

CRWD reports Q1 FY2026 earnings on June 3, 2026 (5 DTE) with a confirmed binary date and an expiry of June 5 exactly 2 calendar days post-event. The stock has had an extraordinary run — up ~60% in the past month (from ~$445 to $726), driven by Snowflake partnership enthusiasm, Falcon Flex momentum, and broad SaaS sentiment recovery. Analyst revisions are unanimously bullish, insider Form-4 purchases密集 over May 13–22 (C-suite buying near all-time highs), and call-skew is pronounced across every strike. The implied ATM straddle (~$70 combined premium on ~$726 spot) prices an approximately 9.6% one-day move — materially richer than CRWD's historical average realized beat/miss of ~4-5%. This rich-implied scenario creates a vol-selling edge: long premium buyers face severe IV crush post-print unless the stock moves >10%, while selling premium into a bullish setup harvests that elevated vol. The technical setup is extended (RSI 84, 52-week high), which raises risk of a short-term pullback on any 'buy the rumor' unwind — but directional conviction from insiders and analysts supports directional defined-risk structures over neutral straddles.

CRWD reports earnings after market close on June 3, 2026 (7 DTE). The stock has been under pressure following the July 2024 Falcon update incident that caused a historic trading halt (-11% in minutes). Recent quarters have shown strong revenue growth ($3.06B FY25 Q4 +14% YoY) but the company faces intense competition from Microsoft and elevated valuation multiples (40-50x forward P/E). Options market is pricing an implied move of approximately 7.5-9%, which appears aligned with or slightly above historical realized moves of ~6-8%. Mixed analyst revisions and put skew suggest cautious positioning. The binary earnings outcome could result in +8-12% on beat (strong net new ARR growth, margin expansion) or -10-15% on miss (deal compression from CrowdStrike's Falcon-only bundling concerns, competitive win-rate issues). At 7 DTE with options expiring June 6, the structure must be defined-risk debit given IV crush risk post-event.

The stock trades at a 107x forward P/E with an RSI of 86.9 and declining EPS surprise magnitude, leaving zero margin for error or mispricing. With no insider buying, heavily covered analyst consensus, and no identifiable edge over the market narrative, this dossier fails to clear the publication threshold.

CrowdStrike is a $169B market cap AI-native cybersecurity platform with FY2026 revenue of $4.81B (+23% YoY), ending ARR of $5.25B, 115% dollar-based net retention, and ~75% gross margins — a high-quality business in secular growth. However, the stock trades at 107x forward P/E near all-time highs (RSI 86.9) with zero insider open-market purchases from executives in the past 90 days; what exists is director selling under pre-set 10b5-1 plans. The primary catalyst is fiscal Q1 FY2027 earnings on June 3, where analysts are uniformly bullish (Morgan Stanley upped target by $100; Stifel at $660), which increases gap-up-or-down risk into the event. No material mispricing exists — CRWD is fully valued and arguably premium-priced relative to intrinsic value.

Extreme valuation (106x Fwd P/E), deeply overbought technicals (RSI 86.6), heavy insider selling, and elevated put demand signal downside hedging rather than an income opportunity; active anti-signals for dilution and liquidity further restrict tradeability.

CrowdStrike is operating from a position of genuine fundamental strength — accelerating revenue (+23% YoY to $4.81B ARR), industry-leading platform consolidation momentum (Omdia Overall Champion 2026), Falcon Flex subscription growth, and robust FCF ($1.60B TTM). However, the stock sits at a fresh 52-week high with RSI of 86.6, forward P/E of ~106x vs sector median ~30-40x for software infrastructure, and an analyst price-target spread of $368-$700 (median $527). Every open-market Form 4 in the past 90 days is selling via CEO/CFO/director 10b5-1 plans — no insider buys whatsoever. Options flow shows a put/call ratio of 1.99 with deep-OTM puts at strikes 17-22% below spot (V/OI ratios 3-4x, new positioning). DZ Bank just issued a Sell rating ($500 target) while KeyBanc is bullish ($700). The setup does not support an asymmetric long; the case for range_bound_or_income is compelling given elevated IV (~66% ATM at June expiry), near-52w-high price, and no margin of safety in valuation. Earnings on June 3 provide a defined catalyst but with the stock this extended and insiders selling into strength, the risk/reward is asymmetric to the downside if guidance disappoints.

Extreme overvaluation (~100x forward P/E), deeply overbought technicals (RSI 84.8), and heavy insider selling ($20M+) present a poor risk/reward profile near a binary earnings event. Anti-signal flags for dilution and customer concentration further justify skipping.

CRWD is hitting all-time highs at $619 (up ~80% from February lows) with an RSI of 84.8 — deeply overbought entering the Q1 FY2027 earnings on June 3 (16 DTE). The company has strong fundamentals: ending ARR reached $5.25B in FY2026, gross margins remain a best-in-class 74.8%, and recent analyst targets from KeyBanc ($700) and BTIG ($621) are being met by the market. However, valuation is extreme (forward P/E ~100x vs sector mid-20s), CEO George Kurtz has been aggressively selling through a 10b5-1 plan throughout May at current prices (no insider buys in 90d), and options flow shows heavy call volume concentrated near ATM strikes suggesting elevated premium sellers rather than directional buyers. The setup is NOT a bullish anomaly — it is a rich, overbought name approaching a binary event with significant smart-money selling into strength.

The investigation reveals a critical disconnect between the trigger signals and reality: all Form 4 activity in the past 30 days is George Kurtz selling shares via a pre-established 10b5-1 plan — not open-market purchases. The CEO sold ~7,300+ shares across May 7-12 alone (at $487-$551), systematically reducing his position into this +44% YTD rally that has pushed the stock to an all-time high of $598. There are zero open-market purchase transactions from any insider in the past 90 days. The options flow shows a strong bullish call skew, but CRWD is at a forward P/E of ~96x with RSI at 82.6 — deeply overbought and pricing in perfection ahead of its June 3 earnings report. No material mispricing exists; the stock has been bid up aggressively by momentum rather than mispriced relative to fundamentals.

Stock is at all-time highs with deeply overbought technicals (RSI 79) and aggressively overvalued multiples (91x forward P/E vs sector ~28x), leaving zero margin of safety. Heavy insider selling and declining EPS surprise history further negate any income or long setup, making this dossier a clear skip.

CRWD has been on a powerful run (+36% YTD to all-time highs) following the DeepSeek/A.I. infrastructure rally and its own positive product announcements (Project QuiltWorks expansion, Frost & Sullivan award). However, the investigation trigger was explicitly 'at least one open-market P/S trade verified' — every single Form 4 filing examined over the past 30 days is a SALE via pre-planned 10b5-1 programs or RSU tax-withholding transactions. No insider has made an open-market PURCHASE in this window. The CEO alone sold ~$23M notional across multiple tranches in April-May through scheduled plans, and the CFO and President similarly sold to cover taxes on vesting equity. Technically, the stock is at 52-week highs with RSI of 79 — deeply overbought. Financially, CRWD trades at a forward P/E of 91x vs. software-infrastructure sector medians near 25-35x, making it one of the most expensive large-cap SaaS names. No mispricing exists; rather the opposite. The catalyst case is modest: Q1 FY27 earnings on June 3 with ~$1.07 EPS expected, but guidance would need to be exceptional to justify current multiples.

The Form 4 cluster trigger (7 filings/14 days) turned out to be almost entirely CEO George Kurtz selling shares pursuant to a pre-established 10b5-1 plan adopted January 6, 2026 — not discretionary open-market purchases. All other recent insiders are either CFO Burt Podbere doing an intra-family trust restructuring (G= gift, no cash), or one independent director receiving RSU-equity in lieu of quarterly retainer. There is zero evidence of insider buying. Meanwhile the stock has surged ~50% from its February 2026 low ($350) to $528 on no material fundamental catalyst — it is stretched: forward P/E of 86x, negative EBITDA/FCF margin at current scale, and RSI of 74.2. The June 3 earnings date provides a named catalyst window, but the elevated put/call ratio (3.06) with deep OTM puts accumulating suggests institutional hedging rather than bullish conviction.